Inventory / revenue moved 188 bp lower
Inventory / revenue changed -188 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed -188 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed -26 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +14.8% from the comparable as-filed period.
Research & development changed +21.2% from the comparable as-filed period.
Inventory changed +12.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cash & equivalents changed -3.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -10.2% from the comparable as-filed period.
Debt changed +0.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.